NASDAQ:TVGN

Tevogen (TVGN) Stock Price, News & Analysis

Tevogen logo
$6.14 +0.45 (+7.91%)
Closing price 04:00 PM Eastern
Extended Trading
$6.03 -0.11 (-1.79%)
As of 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Tevogen Stock (NASDAQ:TVGN)

Advanced

Key Stats

Today's Range
$5.80
▼
$6.19
50-Day Range
$5.11
▼
$7.85
52-Week Range
$3.64
▼
$24.91
Volume
5,185 shs
Average Volume
20,185 shs
Market Capitalization
$421.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$100.00
Consensus Rating
Reduce

Company Overview

Tevogen Inc. is a biotechnology company developing off-the-shelf T-cell therapies. Its approach uses naturally occurring, unmodified immune cells selected to recognize specific targets, with the goal of treating diseases while limiting the need for individualized cell manufacturing.

The company’s programs have focused on infectious diseases and cancer. Its investigational candidate TVGN 489 has been developed for potential use against COVID-19, including in people at elevated risk of severe illness. The company also describes broader applications for its T-cell platform in oncology.

Founded by physician and biotechnology executive Ryan Saadi, Tevogen is based in the United States. Saadi serves as the company’s chief executive officer.

AI Generated. May Contain Errors.

Tevogen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

TVGN MarketRank™: 
1.909885675855 of 5 stars

Tevogen scored higher than 38% of companies evaluated by MarketBeat, and ranked 1379th out of 1,706 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tevogen has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Tevogen has a consensus price target of $100.00, representing about 1,528.7% upside from its current price of $6.14.

  • Amount of Analyst Coverage

    Tevogen has only been the subject of 1 research reports in the past 90 days.

  • Read more about Tevogen's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tevogen is -1.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tevogen is -1.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    2.45% of the float of Tevogen has been sold short.
  • Short Interest Ratio / Days to Cover

    Tevogen has a short interest ratio ("days to cover") of 4.33.
  • Change versus previous month

    Short interest in Tevogen has recently decreased by 1.02%, indicating that investor sentiment is improving.
  • Dividend Yield

    Tevogen does not currently pay a dividend.

  • Dividend Growth

    Tevogen does not have a long track record of dividend growth.

  • News Sentiment

    Tevogen has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Tevogen this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Tevogen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    65.60% of the stock of Tevogen is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Tevogen has minimal institutional ownership at this time.

  • Read more about Tevogen's insider trading history.
Receive TVGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tevogen and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TVGN Stock News Headlines

Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
Tevogen Bio Holdings Rebrands as Tevogen Inc.
See More Headlines

TVGN Stock Analysis - Frequently Asked Questions

Tevogen's stock was trading at $16.5550 on January 1st, 2026. Since then, TVGN shares have decreased by 62.9% and is now trading at $6.14.

Tevogen Inc. (NASDAQ:TVGN) posted its quarterly earnings data on Monday, November, 16th. The company reported ($1.76) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.56) by $0.80.

Shares of Tevogen reverse split before market open on Friday, March 6th 2026.The 1-50 reverse split was announced on Wednesday, March 4th 2026. The number of shares owned by shareholders was adjusted after the market closes on Thursday, March 5th 2026. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of TVGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tevogen investors own include Jaguar Animal Health (JAGX), Micron Technology (MU), NVIDIA (NVDA), D-Wave Quantum (QBTS), Super Micro Computer (SMCI), Tesla (TSLA) and Archer Aviation (ACHR).

Company Calendar

Last Earnings
11/16/2026
Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:TVGN
Previous Symbol
NASDAQ:TVGN
CIK
1860871
Fax
N/A
Employees
18
Year Founded
N/A

Price Target and Rating

High Price Target
$100.00
Low Price Target
$100.00
Potential Upside/Downside
+1,528.7%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.63)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.27 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-495.15%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.33
Quick Ratio
0.33

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($211.84) per share
Price / Book
-0.03

Miscellaneous

Outstanding Shares
68,678,743
Free Float
2,240,000
Market Cap
$421.69 million
Optionable
N/A
Beta
0.21
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NASDAQ:TVGN) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners